Trial Information
A Feasibility Study of Circulating microRNAs as Disease Markers in Pediatric Cancers
Inclusion Criteria:
- All children who are in treatment for leukemia, lymphoblastic lymphoma and central
nervous system tumors
- age: greater than 3 years and less than or equal to 21 years of age
- Patients must be in a phase of their treatment during which routine blood draws,
lumbar punctures or CSF sampling from Ommaya reservoirs are required for treatment of
their cancers.
Exclusion Criteria:
- Patients who have completed treatment and do not require routine blood draws and/or
lumbar punctures
- Patients who are considered too ill to participate as determined by their treating
physician
- Patients with a known genetic condition that predisposed them to the development of
cancer.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Determine if miRNAs are present in the blood of patients with pediatric cancers
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Rishi Lulla, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Ann & Robert H Lurie Children's Hospital of Chicago
Authority:
United States: Institutional Review Board
Study ID:
2010-14205
NCT ID:
NCT01541800
Start Date:
March 2010
Completion Date:
Related Keywords:
- Leukemia
- Lymphoma
- Central Nervous System
- Leukemia
- Lymphoma
Name | Location |
Children's Memorial Hospital |
Chicago, Illinois 60614 |